The FDAnews Webinar Training Pass program offers year-round, unrestricted access to any of the hundreds of webinars listed below. These training programs feature thought leadership and best practices from top consultants, expert speakers and current and former FDA officials. New webinars are offered every month, along with access to the Webinar Training Pass archive.
BUY NOW Single-User 1-Year Unlimited Access $1,362
If you are already a Training Pass member, login below and then scroll down to view the list in date order or narrow your search by keyword or category. Viewing the webinar is easy… simply identify the webinar you want to watch, click on the title and the video will begin. If you would like to view or download the presentation materials separately from the video, click the "Download Presentation" link.
Also available: Take advantage of our multi-user and site licenses of the Webinar Training Pass, so you’ll have the most-informed workforce! Contact Russ Titsch, Business Development Director at russ.titsch@wcgclinical.com or +1 703.538.7651 to receive a custom quote.
Search by keyword, speaker name or just by category (drug, device or clinical) and you'll find all you need.
If you have any questions or are having any problems please give us a call on 703.538.7600 or email customer service.
Webinar Training Pass
Recorded on: Feb. 6, 2020
Description: Quality management expert Bethany Kearney presents methods for transitioning to digital quality management methods. She discusses:
- What an enterprise cloud quality management system solution should include;
- Using quality data to move from reactive compliance to proactive performance; and
- Utilizing emerging technologies to improve decisionmaking.
Presentation: Download the presentation
Transcript: Download the transcript
Speaker: Bethany Kearney, Industry Best Practices CoE, Professional Services, Sparta Systems
Recorded on: Jan. 28, 2020
Description: Industrial-organizational psychologist Ginette Collazo discusses how to comply with regulations on cannabis-containing products. She covers:
- How the FDA is regulating cannabis, including how GMPs apply to the medical cannabis industry;
- How Canada and Europe are regulating cannabis, including how to comply with comparable GMP regulations from different jurisdictions; and
- Best practices for dealing with personnel requirements, process controls, procedures development, quality controls and analytical testing in cannabis production.
Presentation: Download the presentation
Transcript: Download the transcript
Speaker: Ginette Collazo, Founder, Human Error Solutions
Recorded on: Jan. 23, 2020
Description: Data specialists Mary Jo Lamberti and Francis Kendall discuss the use of real-world evidence (RWE) in drug development. Topics include:
- Types of technology used to access or collect RWE;
- The key drivers for change and the adoption of RWE; and
- The potential of RWE and how it may be used across the clinical development pipeline.
Presentation: Download the presentation
Transcript: Download the transcript
Speakers: Mary Jo Lamberti, Associate Director of Sponsored Research, Tufts CSDD, and Francis Kendall, Senior Director, Cytel
Recorded on: Jan. 22, 2020
Description: Computer system validation expert David Harrison shares best practices and available options for validating spreadsheets. He discusses:
- FDA examples of noncompliance and regulatory concerns with respect to 21 CFR 210-211, 21 CFR Part 11 and 21 CFR Part 820;
- How to determine spreadsheet validation gaps the FDA targets;
- How to choose an approach for efficient and repeatable validation that fits into your traditional QA and validation processes; and
- How to plan, manage and resource an effective project.
Presentation: Download the presentation
Transcript: Download the transcript
Speaker: David Harrison, Principal Consultant, CSV Compliance
Recorded on: Jan. 21, 2020
Description: Regulatory expert Grace Fu Palma provides an update on medical device regulatory reform in China. She discusses:
- New postmarket surveillance regulations and implications in adverse events and recalls reporting;
- What the regulations and requirements forecast for overseas inspections; and
- Common issues in GMP compliance.
Presentation: Download the presentation
Transcript: Download the transcript
Speaker: Grace Fu Palma, CEO, China Med Device
Recorded on: Jan. 14, 2020
Description: Compliance experts Cynthia Schnedar and Liz Oestreich discuss issues surrounding data integrity. Topics include:
- Developing an organizational culture of quality that ensures data integrity;
- FDA enforcement activity; and
- Recent data integrity failures in the news.
Presentation: Download the presentation
Transcript: Download the transcript
Speakers: Cynthia Schnedar, Executive Vice President, and Liz Oestreich, Vice President, Greenleaf Health
Recorded on: Dec. 18, 2019
Description: : Consultant and former FDA investigator Ricki Chase explains how to navigate the FDA’s Adverse Event Reporting System. She discusses:
- The difference between serious unexpected and serious expected events;
- Common inspection observations related to adverse events; and
- What not to report.
Presentation: Download the presentation
Transcript: Download the transcript
Speaker: Ricki Chase, Executive Director, Lachman Consultant Services
Recorded on: Dec. 17, 2019
Description: A panel of quality systems experts discuss the benefits of using cloud technology solutions. They cover:
- Regulatory impact;
- Hybrid cloud approach; and
- Validating cloud solutions.
Presentation: Download the presentation
Transcript: Download the transcript
Speakers: Ashley Wentworth, Director of Strategy, Vault Quality, Veeva Systems; Robert Lorence, Managing Director, PwC Consulting; Jhumki Sen, Senior Manager, PwC Consulting
Recorded on: Dec. 16, 2019
Description: Biologics development Scott Burger presents strategies for successful BLA submissions. He discusses:
- FDA requirements for cell therapy or gene therapy BLAs;
- What reviewers in the Office of Tissues and Advanced Therapies expect to see;
- How a cell or gene therapy BLA fits into the framework of the common technical document; and
- How the earlier stages in development affect the content of the BLA.
Presentation: Download the presentation
Transcript: Download the transcript
Speaker: Scott Burger, Principal, Advanced Cell and Gene Therapy
Recorded on: Dec. 12, 2019
Description: Device industry veteran Jon Speer presents best practices, tips and pointers for internal company change control processes and practices. He discusses:
- The different types of change and how each should be managed;
- How to assure a risk-based approach to change management; and
- How technology solutions can help streamline change management.
Presentation: Download the presentation
Transcript: Download the transcript
Speaker: Jon Speer, Co-founder and Vice President of QA/RA, Greenlight Guru